![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Choueiri Michel
Publisher: Springer Publishing Company
ISSN: 0167-7659
Source: Cancer and Metastasis Reviews, Vol.25, Iss.4, 2006-12, pp. : 601-609
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
By Ni Jie
Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metastasis Suppression in Prostate Cancer
By Jaeger E.B.
Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis
Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endoglin suppresses human prostate cancer metastasis
Clinical and Experimental Metastasis, Vol. 28, Iss. 1, 2011-01 ,pp. :